Example: Bible, Android

  • PDF
  • DOC
  • XLS
  • RTF
  • TXT
  • PPT

Braf inhibitor PDF results

Combinations of braf, mek, and pi3k/mtor inhibitors overcome ...

Preclinical development combinations of braf, mek, and pi3k/mtor inhibitors overcome acquired resistance to the braf inhibitor gsk2118436 dabrafenib...

Mounting concerns about braf inhibitor resistance

April 12, 2011 marc engelsgjerd, md the 102 nd annual meeting of the american association for cancer research (aacr) last week in orlando gave glimpses into new...

Description of procedure or service

Corporate medical policy page 1 of 3 an independent licensee of the blue cross and blue shield association braf gene mutation testing to select melanoma patients for...

Melanoma: three ways around braf inhibition

Analysis reprint from december 9, 2010 1 from the makers of and melanoma: three ways around braf inhibition

Improved survival with vemurafenib in melanoma with braf ...

The new england journal of medicine 10.1056/nejmoa1103782 nejm.org 1 original article improved survival with vemurafenib in melanoma with braf v600e mutation

Will two kinase inhibitors be better than one?

September 20, 2011 david yee, phd the recent approval of roche (rhhby) and daiichi sankyo's braf v600e inhibitor zelboraf (vemurafenib) is good news for...

Product development pipeline

Biopharmaceuticals 1070806 il18 monoclonal antibody type 2 diabetes & inflammatory bowel disease i 1223249 neurite outgrowth inhibitor (nogo-a) amyotrophic...

Phase i/ii study of brafi - gsk1120212 in patients with braf ...

Phase i/ii study of brafi gsk2118436 + meki gsk1120212 in patients with braf mutant metastatic melanoma who progressed on a prior brafi keith flaherty 1...

Th 58 meeting of the nci director's consumer liaison group ...

58th meeting of the nci director's consumer liaison group, september 2123, 2011- meeting bibliography. abbruzzese • hanahan d, weinberg ra.

How science conducted in the lab is changing the structure of ...

How science conducted in the lab is changing the structure of clinical trials molecular profiling of thoracic malignancies. giuseppe giaccone, md phd

Targeting the pi3k-akt-mtor pathway with gdc-0068, a novel ...

Targeting the pi3k-akt-mtor pathway with gdc-0068, a novel selective atp competitive akt inhibitor josep tabernero, andrés cervantes, cristina saura, desamparados roda,

Targeted therapy for metastatic melanoma

386 clinical advances in hematology & oncology volume 5, issue 5 may 2007 targeted therapy for metastatic melanoma ravi k. amaravadi, md, and keith t. flaherty, md

Kit mutation analysis in melanoma

©2010 arup laboratories. all rights reserved. may 2010 500 chipeta way, salt lake city, ut 84108 | (800) 522-2787 | (801) 583-2787 | www.aruplab.com |...

Use of next-generation sequencing (ngs) to detect a novel alk ...

Increasing coverage to use of next-generation sequencing (ngs) to detect a novel alk fusion and a high frequency of other actionable alterations in colorectal cancer

Top Queries


Recent Searches

 
DOC-TXT